7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

PhaseBio Pharmaceuticals, Inc
(NASDAQ:PHAS) 

PHAS stock logo

PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiopulmonary diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical ...

Founded: 2002
Full Time Employees: 50 (May 2021)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
PhaseBio Pharmaceuticals Op Cashflow Per Share ttm
202208 202209 202210 202211 202212 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.61-1.38-1.15-0.92-0.69-0.46-0.230
PhaseBio Pharmaceuticals Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.7-1.46-1.22-0.97-0.73-0.49-0.240
PhaseBio Pharmaceuticals Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.20.410.610.811.021.221.42
PhaseBio Pharmaceuticals P/S ratio ttm
202208 202209 202210 202211 202212 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -5.3663.89133.14202.39271.64340.89410.13479.38
PhaseBio Pharmaceuticals (GAAP) P/E ratio ttm
202208 202209 202210 202211 202212 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -15.72-12.93-10.14-7.35-4.56-1.771.023.81
PhaseBio Pharmaceuticals P/B ratio ttm
202208 202209 202210 202211 202212 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.6-0.51-0.43-0.34-0.26-0.17-0.090
No extra charts and metrics for this ticker.